[18F]CYP2108

[18F]CYP2108 is a radiopharmaceutical compound labeled with the positron-emitting radioisotope fluorine-18 (18F), designed for use in positron emission tomography (PET) imaging. It is used as a PET tracer for brain imaging, and has been evaluated in clinical studies involving healthy volunteers, where it was administered following standard MRI and [18F]FDG-PET/CT scans to assess its imaging characteristics. The specific molecular target or mechanism of action of [18F]CYP2108 has not been detailed in the available literature, but as an 18F-labeled agent, it likely functions by binding to or accumulating in specific tissues or molecular targets relevant to neurological conditions or brain function. Its development reflects ongoing efforts to expand the repertoire of PET tracers for improved diagnostic accuracy in neuroimaging[8].